ABALLI JOHN

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 24% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
7 43% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 157%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
ABALLI JOHN's trades of Exagen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Exagen Inc (XGN)
Transaction date
Sale
Price
475.14
Quantity 17,317 -24.6%
Value US$249,687
US Exagen Inc (XGN)
Transaction date
Sale
Price
81.31
Quantity 26,439 -26.3%
Value US$2,480,384
US Exagen Inc (XGN)
Transaction date
Sale
Price
432.26
Quantity 38,362 -30.5%
Value US$3,274,612
US Exagen Inc (XGN)
Transaction date
Sale
Price
11.82
Quantity 31,787 -4.3%
Value US$375,598
US Exagen Inc (XGN)
Transaction date
Purchase
Price
2.81
Quantity 24,305 +3.7%
Value US$68,297
US Exagen Inc (XGN)
Transaction date
Purchase
Price
1.92
Quantity 40,401 +inf%
Value US$77,570
US Exagen Inc (XGN)
Transaction date
Sale
Price
1.75
Quantity 33,819 -7.5%
Value US$59,018
US Exagen Inc (XGN)
Transaction date
Purchase
Price
2.68
Quantity 90,000 +25.7%
Value US$241,200
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-19 2026-10-16
US Exagen Inc (XGN)
S Sale
17,317 -24.6%
475.14
US$249,687 		17,317 -24.6% 475.14 US$249,687
2026-03-04 2026-03-03
US Exagen Inc (XGN)
S Sale
26,439 -26.3%
81.31
US$2,480,384 		26,439 -26.3% 81.31 US$2,480,384
2026-02-25 2026-02-24
US Exagen Inc (XGN)
S Sale
38,362 -30.5%
432.26
US$3,274,612 		38,362 -30.5% 432.26 US$3,274,612
2025-10-20 2025-10-16
US Exagen Inc (XGN)
S Sale
31,787 -4.3%
11.82
US$375,598 		31,787 -4.3% 11.82 US$375,598
2024-11-18 2024-11-14
US Exagen Inc (XGN)
B Purchase
24,305 +3.7%
2.81
US$68,297 		24,305 +3.7% 2.81 US$68,297
2024-05-16 2024-05-16
US Exagen Inc (XGN)
B Purchase
40,401 +inf%
1.92
US$77,570 		40,401 +inf% 1.92 US$77,570
2023-10-18 2023-10-17
US Exagen Inc (XGN)
S Sale
33,819 -7.5%
1.75
US$59,018 		33,819 -7.5% 1.75 US$59,018
2022-12-09 2022-12-08
US Exagen Inc (XGN)
B Purchase
90,000 +25.7%
2.68
US$241,200 		90,000 +25.7% 2.68 US$241,200